<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ami_virus_4\PMC7290594\results\search\tropicalVirus\results.xml">
  <result pre="West African Ebola epidemic, the resurgence of yellow fever, the" exact="Zika" post="virus emergency, and the return of a global coronavirus"/>
  <result pre="clinical trials, only low to modest efficacy was observed against" exact="DENV" post="serotype 1 and 2 [18,19]. Controlled human infection model"/>
  <result pre="that are either transmitted by mosquitoes (dengue, Zika, yellow fever," exact="West Nile," post="and Japanese encephalitis virus) or by ticks (tick-borne encephalitis,"/>
  <result pre="or by ticks (tick-borne encephalitis, Powassan virus) [70]. The recent" exact="Zika" post="pandemic witnessed more than 3700 cases of congenital birth"/>
  <result pre="more than 3700 cases of congenital birth defects linked to" exact="Zika" post="virus infection in the Americas and was declared by"/>
  <result pre="in February 2016 to be a public health emergency [71]." exact="Dengue" post="infections, on the other hand, account for 390 million"/>
  <result pre="protects against re-infection, but only short-term protection against the heterologous" exact="DENV" post="serotype challenge for up to six months [75,76]. Moreover,"/>
  <result pre="produced greater neutralizing antibody responses and protection against the wild-type" exact="DENV" post="infection compared to seronegative vaccinees [19,81,82]. These studies were"/>
  <result pre="as waning cross-reactive antibodies that are acquired from a heterotypic" exact="DENV" post="infection or through maternal-fetal transmission can result in a"/>
  <result pre="including Ebola, Severe Acute Respiratory Syndrome coronavirus-2 (SARS CoV-2), and" exact="Zika" post="viruses. Acknowledgments Figures are made with the help of"/>
  <result pre="World War IIAm. J. Trop. Med. Hyg.19521305010.4269/ajtmh.1952.1.3014903434 77.GuzmÃ¡nM.G.KouriG.ValdesL.BravoJ.AlvarezM.VazquesS.DelgadoI.HalsteadS.B.Epidemiologic Studies on" exact="Dengue" post="in Santiago de Cuba, 1997Am. J. Epidemiol.200015279379910.1093/aje/152.9.79311085389 78.KatzelnickL.C.GreshL.HalloranM.E.MercadoJ.C.KuanG.GordonA.BalmasedaA.HarrisE.Antibody-dependent enhancement"/>
  <result pre="Latin AmericaN. Engl. J. Med.201537211312310.1056/NEJMoa141103725365753 82.BiswalS.ReynalesH.Saez-LlorensX.LopezP.Borja-TaboraC.KosalaraksaP.SirivichayakulC.WatanaveeradejV.RiveraL.EspinozaF.et al.Efficacy of a Tetravalent" exact="Dengue" post="Vaccine in Healthy Children and AdolescentsN. Engl. J. Med.20193812009201910.1056/NEJMoa190386931693803"/>
  <result pre="Mol. Med.200810e1210.1017/S146239940800066518471342 97.PiersonT.C.XuQ.NelsonS.OliphantT.NybakkenG.E.FremontD.H.DiamondM.S.The stoichiometry of antibody-mediated neutralization and enhancement of" exact="West Nile" post="virus infectionCell Host Microbe2007113514510.1016/j.chom.2007.03.00218005691 98.PiersonT.C.FremontD.H.KuhnR.J.DiamondM.S.Structural Insights into the Mechanisms"/>
  <result pre="in Cells Expressing Fc Gamma ReceptorsPLoS ONE20138e6523110.1371/journal.pone.006523123717696 111.RodrigoW.W.S.I.JinX.BlackleyS.D.RoseR.C.SchlesingerJ.J.Differential Enhancement of" exact="Dengue" post="Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent"/>
  <result pre="mediated by FcÎ³RI versus FcÎ³RIIaBlood200911431832710.1182/blood-2008-10-18445719420354 113.FlipseJ.Diosa-ToroM.A.HoornwegT.E.van de PolD.P.I.Urcuqui-InchimaS.SmitJ.M.Antibody-Dependent Enhancement of" exact="Dengue" post="Virus Infection in Primary Human Macrophages; Balancing Higher Fusion"/>
 </snippets>
</snippetsTree>
